Human HER1 Protein, His Tag, Avi Tag
-
产品编号
KMP2271
-
别名
表皮生长因子受体, Epidermal growth factor receptor, EGFR
-
规格
- 50ug
- 100ug
- 200ug
| Catalog Number | KMP2271 |
| Alias | 表皮生长因子受体, Epidermal growth factor receptor, EGFR |
| Size | 50ug, 100ug, 200ug |
| Product Description | The Human HER1 Protein(KMP2271) is produced in HEK293 Cells and the target gene encoding Leu25-Ser378 is expressed with a 6His, Avi tag at the C-terminus. |
| Molecular Name | HER1 |
| Product Introduction | HER1(EGFR):受体酪氨酸激酶家族跨膜蛋白,通过配体结合介导细胞增殖和分化信号。 |
| Molecular Weight | 39.6 kDa |
| Expression System | HEK293 Cells |
| Species | Human |
| Purity | >95% |
| Purification | Affinity Purification |
| Uniprot ID | P00533 |
| Storage Condition | Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.4 |
| Shipping Condition | In general, the proteins are provided as lyophilized powder which are shipped at ambient temperature. They are shipped out in dry ice if supplied in liquid form. |
| Background | The EGFR subfamily of receptor tyrosine kinases is composed of EGFR, ErbB2, ErbB3 and ErbB4. The EGFR shares 43% - 44% aa sequence identity with the ECD of human EGFR subfamily. All these family members are type I transmembrane glycoproteins with an extracellular ligand binding domain. The extracellular ligand binding domain is containing two cysteine-rich domains separated by a spacer region and a cytoplasmic domain containing a membrane-proximal tyrosine kinase domain. Ligand binding could induce EGFR homodimerization and heterodimerization with ErbB2, resulting in cell signaling, heterodimerization tyrosine phosphorylation and kinase activation. It can bind EGF, amphiregulin, TGF-alpha, betacellulin, epiregulin, HB-EGF, epigen, and so on. Its signaling regulates multiple biological functions including cell proliferation, differentiation, motility, and apoptosis. EGFR can also be recruited to form heterodimers with the ligand-activated ErbB3 or ErbB4. EGFR is overexpressed in different tumors. Several anti-cancer drugs use EGFR as target. |
| Endotoxin | <1.0 EU/ug determined by the LAL method |
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 |
0